Primary malignant melanoma of the esophagus treated by endoscopic ablation and interferon therapy
Language English Country United States Media print
Document type Case Reports, Journal Article
PubMed
11869328
DOI
10.1046/j.1442-2050.2001.00192.x
PII: 192
Knihovny.cz E-resources
- MeSH
- Esophagoscopy methods MeSH
- Risk Assessment MeSH
- Interferons administration & dosage MeSH
- Biopsy, Needle MeSH
- Combined Modality Therapy MeSH
- Middle Aged MeSH
- Humans MeSH
- Melanoma diagnosis pathology therapy MeSH
- Esophageal Neoplasms diagnosis pathology therapy MeSH
- Follow-Up Studies MeSH
- Treatment Outcome MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Names of Substances
- Interferons MeSH
Primary malignant melanoma of the esophagus is a rare illness accounting for 0.1-0.2% of malignant diseases of the esophagus; however, the incidence of the disease appears to be rising. The average survival time is between 10 and 15 months. The authors describe the 25 month follow up of a patient with primary malignant melanoma of the esophagus which was treated with endoscopic ablation followed by interferon therapy. No other focus was found and the patient is undergoing regular endoscopic check-ups, currently without any problems.
References provided by Crossref.org
